Bipartisan Senators Introduce Comprehensive 340B Program Reform Bill

Senators Tammy Baldwin and Jerry Moran introduced the 340B Program Integrity and Transparency Act. The bill aims to reform the drug discount program by imposing new reporting requirements on covered entities and manufacturers, clarifying patient and contract pharmacy definitions, and increasing oversight. It seeks to address years of litigation and payer pushback by establishing clearer program rules. The legislative text is not yet public, but the move indicates a serious congressional effort to stabilize the program after a decade of expansion and controversy. Track the bill's progress; final language will dictate new compliance obligations for hospitals and clinics participating in 340B.